Charles River Laboratories (CRL)
Deferred Revenue
$203.04M
Quarterly · Period ending: · USD
CRL Deferred Revenue
Latest reported$210.42Mperiod ending
Latest reported$210.42Mperiod ending
CRL FY Deferred Revenue ($39.22M → $210.42M)
Annual deferred revenue
High-resolution chart · PNG
CRL deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 210,418,000 | |
| 248,322,000 | |
| 241,820,000 | |
| 264,259,000 | |
| 219,703,000 | |
| 250,186,000 | |
| 204,885,000 | |
| 145,139,000 | |
| 117,569,000 | |
| 127,731,000 | |
| 81,343,000 | |
| 78,124,000 | |
| 54,177,000 | |
| 56,422,000 | |
| 56,530,000 | |
| 66,905,000 | |
| 72,390,000 | |
| 86,707,000 | |
| 102,021,000 | |
| 93,197,000 | |
| 116,302,000 | |
| 117,490,000 | |
| 30,846,000 | |
| 27,029,000 | |
| 22,210,000 | |
| 0 | |
| 0 | |
| 39,216,000 |